Found: 6
Select item for more details and to access through your institution.
Inhibition of the mammalian target or rapamycin (mTOR): a potential therapeutic strategy for multiple system atrophy.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Induced pluripotent stem cells in multiple system atrophy: recent developments and scientific challenges.
- Published in:
- Clinical Autonomic Research, 2019, v. 29, n. 4, p. 385, doi. 10.1007/s10286-019-00614-y
- By:
- Publication type:
- Article
Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenotyping.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Clinical Trial-Ready Patient Cohorts for Multiple System Atrophy: Coupling Biospecimen and iPSC Banking to Longitudinal Deep-Phenotyping.
- Published in:
- Cerebellum, 2024, v. 23, n. 1, p. 31, doi. 10.1007/s12311-022-01471-8
- By:
- Publication type:
- Article
Iron in Neurodegeneration – Cause or Consequence?
- Published in:
- Frontiers in Neuroscience, 2019, p. N.PAG, doi. 10.3389/fnins.2019.00180
- By:
- Publication type:
- Article
TNFα inhibitors as targets for protective therapies in MSA: a viewpoint.
- Published in:
- 2019
- By:
- Publication type:
- journal article